<p>Data are shown as adjusted RR, adjusted OR, or SIR, plus 95% CIs, for the risk of upper gastrointestinal bleeding with low-dose aspirin vs no aspirin. <sup>a</sup>One dose equals one 325 mg tablet; <sup>b</sup>adjusted RR; <sup>c</sup>Adjusted OR; <sup>d</sup>SIR. CI, confidence interval; OR, odds ratio; RR, relative risk; SIR standardized incidence ratio.</p
Assessment of both GI and CV risks vs. the benefits of low-dose aspirin for individual patients can ...
Very few studies have examined the risk of short-term adverse hemorrhage of low-dose aspirin use in ...
Estimates of the effect of proton pump inhibitors (PPIs) on risks of upper and lower gastrointestina...
Introduction: Risks of low-dose aspirin-associated upper and lower gastrointestinal bleeds (UGIB/LGI...
†<p>Relative risks (RR) are compared to non-users as reference group.</p><p>*Includes 101 individual...
†<p>Relative risks (RR) are compared to those without any continuous aspirin use as reference group....
Data regarding the influence of dose and duration of aspirin use on risk of gastrointestinal bleedin...
†<p>Regular aspirin use is defined as consumption of ≥2 times per week<b>.</b> Non-regular use is de...
Low-dose aspirin has proven effectiveness in secondary and primary prevention of cardiovascular even...
Data regarding the influence of dose and duration of aspirin use on risk of gastrointestinal bleedin...
<div><p>Background</p><p>Low-dose aspirin has proven effectiveness in secondary and primary preventi...
Aspirin has been shown to lower the incidence and the mortality of vascular disease and cancer but i...
<p>Abbreviations: CI, confidence interval; RR, relative risk.</p><p>*Incidence rate/1000 person-year...
Background: Aspirin has been shown to lower the incidence and the mortality of vascular disease and ...
In the first part of this thesis we developed a novel prediction score for predicting upper gastroin...
Assessment of both GI and CV risks vs. the benefits of low-dose aspirin for individual patients can ...
Very few studies have examined the risk of short-term adverse hemorrhage of low-dose aspirin use in ...
Estimates of the effect of proton pump inhibitors (PPIs) on risks of upper and lower gastrointestina...
Introduction: Risks of low-dose aspirin-associated upper and lower gastrointestinal bleeds (UGIB/LGI...
†<p>Relative risks (RR) are compared to non-users as reference group.</p><p>*Includes 101 individual...
†<p>Relative risks (RR) are compared to those without any continuous aspirin use as reference group....
Data regarding the influence of dose and duration of aspirin use on risk of gastrointestinal bleedin...
†<p>Regular aspirin use is defined as consumption of ≥2 times per week<b>.</b> Non-regular use is de...
Low-dose aspirin has proven effectiveness in secondary and primary prevention of cardiovascular even...
Data regarding the influence of dose and duration of aspirin use on risk of gastrointestinal bleedin...
<div><p>Background</p><p>Low-dose aspirin has proven effectiveness in secondary and primary preventi...
Aspirin has been shown to lower the incidence and the mortality of vascular disease and cancer but i...
<p>Abbreviations: CI, confidence interval; RR, relative risk.</p><p>*Incidence rate/1000 person-year...
Background: Aspirin has been shown to lower the incidence and the mortality of vascular disease and ...
In the first part of this thesis we developed a novel prediction score for predicting upper gastroin...
Assessment of both GI and CV risks vs. the benefits of low-dose aspirin for individual patients can ...
Very few studies have examined the risk of short-term adverse hemorrhage of low-dose aspirin use in ...
Estimates of the effect of proton pump inhibitors (PPIs) on risks of upper and lower gastrointestina...